Capgemini Shares Rise 1.2% Midday After Announcement from its U.S. Subsidiary
Capgemini's stock advances 1.22% this Monday, February 2nd, at midday, reaching 132.80 euros. This increase follows the IT services company's announcement of its intention to sell a U.S. subsidiary specializing in classified activities. The matter is also attracting renewed interest from financial analysts.
Formal Announcement of the U.S. Subsidiary Sale
The Paris-based group formalized this Monday the sale of an American subsidiary operating with federal institutions in classified activities, including immigration enforcement. According to the company, this decision is due to specific regulatory constraints in the United States that prevent the parent company from exercising proper control over this entity. The press release published on February 2nd details that American legal restrictions make it impossible to supervise in accordance with the group's standards.
This operation is part of a strategy to optimize the scope of activities, allowing the group to refocus on areas where it can fully exercise its governance. The announcement comes just days before the publication of the annual results for 2025, scheduled for February 13th. Investors are also awaiting the first quarter revenue figures, which will be announced at the end of April, before the general meeting set for May 20th.
Mixed Positions from Brokerage Houses
Brokerage houses display contrasting positions on the matter. Oddo BHF maintains its 'Outperform' recommendation this Monday with a target price set at 180 euros, representing a potential upside of 35.5% from the current level. This optimistic outlook contrasts with the more cautious approach of Berenberg, which recommends holding the stock with a target of 143 euros established on January 22nd.
Technically, the stock is trading below its 50-day (140.35 euros) and 200-day (135.52 euros) moving averages, reflecting an overall unfavorable trend. The 30-point relative strength index signals a potential oversold zone, while the support identified at 127.85 euros remains nearby. The monthly volatility of 9.71% indicates persistent nervousness in the stock, which has declined 24.52% over the past year.
